nepafenac 0.1%
Sponsors
Alcon Research, Clinica Oftamologica Zona Sul, Frank A. Bucci, Jr., M.D., Queen's University, Sheba Medical Center
Conditions
CataractCataractsEpiretinal MembraneGlaucoma, Angle-ClosureGlaucoma, Closed-AngleGlaucoma, Narrow-AngleMacular EdemaPhotorefractive Keratectomy
Phase 4
A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief
CompletedNCT00330798
Start: 2006-02-28End: 2006-06-30Updated: 2016-11-18
Role of Nepafenac in Reducing Macular Volume After Epiretinal Membrane Surgery
CompletedNCT00818844
Start: 2009-01-31End: 2010-06-30Updated: 2015-08-14
Effect of Anti-inflammatory Topical Prednisolone, Nepafenac and Ketorolac in Intra-operative Mydriasis in Facetectomies
NCT00865540
Start: 2009-03-31End: 2011-08-31Updated: 2011-05-24
A Comparison of Peak Aqueous Penetration of Acuvail (Ketorolac 0.45%), Xibrom (Bromfenac 0.09%), and Nevanac (Nepafenac 0.1%)in Patients Undergoing Phacoemulsification
CompletedNCT01001806
Start: 2009-10-31End: 2010-01-31Updated: 2011-10-03
Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery
CompletedNCT01395069
Start: 2010-02-28End: 2011-05-31Updated: 2016-01-13